Mar 2, 2026 02:38AM Morgan Stanley Downgrades Aardvark Therapeutics Inc (AARD) to Equalweight

Mar 2, 2026 12:41AM RBC Capital Downgrades Aardvark Therapeutics Inc (AARD) to Sector Perform

Feb 12, 2026 08:03AM Aardvark Therapeutics names new business officer, expands CFO role

Jan 28, 2026 02:18AM B.Riley Starts Aardvark Therapeutics Inc (AARD) at Buy

Jan 12, 2026 04:47AM Raymond James Reiterates Strong Buy Rating on Aardvark Therapeutics Inc (AARD)

Dec 23, 2025 06:04AM Oppenheimer Starts Aardvark Therapeutics Inc (AARD) at Outperform

Dec 12, 2025 04:06AM William Blair Starts Aardvark Therapeutics Inc (AARD) at Outperform

Dec 11, 2025 03:55PM BTIG:'Phase 3 HERO Update and RYTM PWS Phase 2 Data Read Positively to AARD'

Dec 11, 2025 12:23PM Raymond James on Aardvark (AARD): 'we think ARD-101’s value proposition as potentially best-in-class

Dec 2, 2025 04:06PM Raymond James Starts Aardvark Therapeutics Inc (AARD) at Strong Buy, PT $47, 'we think this name is worth a hard look right here'

Nov 14, 2025 07:58AM Aardvark's (AARD) Registrational ph3 HERO RCT in PWS Remains On Track - Stifel

Nov 14, 2025 07:08AM Cantor Fitzgerald Reiterates Overweight Rating on Aardvark Therapeutics Inc (AARD)

Nov 14, 2025 04:30AM Aardvark Therapeutics Inc (AARD) PT Lowered to $18 at RBC Capital

Nov 13, 2025 06:52PM Aardvark Therapeutics, Inc. (AARD) Tops Q3 EPS by 2c

Nov 7, 2025 06:06AM BTIG Starts Aardvark Therapeutics Inc (AARD) at Buy

Sep 30, 2025 04:31PM Jones Trading Starts Aardvark Therapeutics Inc (AARD) at Buy

Sep 29, 2025 12:47AM Stifel Starts Aardvark Therapeutics Inc (AARD) at Buy

Sep 23, 2025 06:36AM H.C. Wainwright Reiterates Buy Rating on Aardvark Therapeutics Inc (AARD)

Aug 21, 2025 08:00AM Cantor Fitzgerald Reiterates Overweight Rating on Aardvark Therapeutics Inc (AARD)

Aug 14, 2025 10:48AM Aardvark Therapeutics Inc (AARD) PT Lowered to $19 at RBC Capital

Aug 14, 2025 07:24AM Cantor Fitzgerald Reiterates Overweight Rating on Aardvark Therapeutics Inc (AARD)

Aug 13, 2025 05:52PM Aardvark Therapeutics, Inc. (AARD) Tops Q2 EPS by 4c

Aug 12, 2025 08:04AM Aardvark Therapeutics reports positive preclinical data for ARD-201

Jun 30, 2025 06:40AM H.C. Wainwright Starts Aardvark Therapeutics Inc (AARD) at Buy

May 19, 2025 04:15PM Aardvark Therapeutics (AARD) announces new management appointments

Apr 1, 2025 08:18AM RBC Capital on Aardvark Therapeutics Inc (AARD): 'We See Substantial Upside Potential On Positive Data'

Apr 1, 2025 07:11AM Cantor Fitzgerald Reiterates Overweight Rating on Aardvark Therapeutics Inc (AARD)

Mar 27, 2025 05:18AM Aardvark Therapeutics Inc (AARD) PT Raised to $26 at BofA Securities

Mar 26, 2025 09:45AM Truist Weighs In on Obesity: 'Catalyst-Rich 2025 Ahead in a Growing Competitive Landscape'

Mar 10, 2025 06:23AM RBC Capital Starts Aardvark Therapeutics Inc (AARD) at Outperform

Mar 10, 2025 05:16AM BofA Securities Starts Aardvark Therapeutics Inc (AARD) at Buy

Mar 10, 2025 01:57AM Morgan Stanley Starts Aardvark Therapeutics Inc (AARD) at Overweight

Jan 23, 2025 05:01PM Aardvark Therapeutics (AARD) Files for Proposed IPO